Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Lymphoma, Large B-Cell, Diffuse 40Lymphoma 37Lymphoma, Follicular 33Leukemia, Lymphocytic, Chronic, B-Cell 32Lymphoma, Mantle-Cell 23Lymphoma, Non-Hodgkin 22Lymphoma, B-Cell, Marginal Zone 19Burkitt Lymphoma 19Waldenstrom Macroglobulinemia 14Leukemia 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, Large-Cell, Immunoblastic 10Multiple Myeloma 6Lymphoma, B-Cell 6Leukemia, Hairy Cell 6Hodgkin Disease 6Leukemia, Prolymphocytic 5Myelodysplastic Syndromes 4Lymphoma, AIDS-Related 4Dendritic Cell Sarcoma, Interdigitating 4Plasmablastic Lymphoma 3Lymphoma, Primary Effusion 3Lymphoma, Large-Cell, Anaplastic 3HIV Infections 3Epstein-Barr Virus Infections 3Neoplasms, Plasma Cell 2Neoplasms 2Neoplasm, Residual 2Myeloproliferative Disorders 2Lymphoproliferative Disorders 2

Interventions

siplizumab 1liposomal doxorubicin 1Vincristine 1Rituximab 1Prednisone 1Etoposide 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Subcutaneous panniculitis-like T-cell lymphoma × Rituximab × Clear all
NCT01445535 2021-11-03

Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
15 enrolled 18 charts
DermatologicLymphoid

Subcutaneous panniculitis-like T-cell lymphoma, Lymphoma, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡